Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this podcast episode, listen to Ursula Matulonis, MD, and Jubilee Brown, MD, discuss new data for gynecological cancers presented at the virtual SGO 2021 meeting, including immunotherapy-based combinations for endometrial cancer and PARP inhibitors for BRCA-mutated ovarian cancers.
This podcast is intended for clinicians practicing medicine outside of the United States.
In this episode, Jubilee Brown, MD, and Ursula Matulonis, MD, provide expert perspectives on new data from SGO 2021 presented for endometrial and ovarian cancer including:
Jubilee Brown, MD
Professor and Director of Gynecologic Oncology
Levine Cancer Institute
Charlotte, North Carolina
Ursula Matulonis, MD
Chief, Division of Gynecologic Oncology
Brock Wilson Family Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2021, from Clinical Care Options (CCO)
Commentaire clinique en français sur la reclassification moléculaire des cancers de l'endomètre et les principaux essais d'immunothérapie en cours, de Clinical Care Options (CCO)
Clinical Care Options（CCO）からの、子宮内膜がんの分子的再分類と、進行中の重要な免疫療法についての臨床的コメント（中国語）
Video from Clinical Care Options (CCO) of a panel of international experts reviewing the role of immunotherapy for patients with endometrial cancer.